Sponsor pipeline

Replimune, Inc. clinical trial pipeline

Get alerts when Replimune, Inc.'s trials change

3 active trials 1 recruiting 1 Phase 3 1 disease areas

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

Active trials by phase

Phase 1/2
1
Phase 2
1
Phase 3
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT06264180 VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1… Advanced Melanoma Recruiting 2026-07-15
Phase 2
NCT04050436 Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous… Cutaneous Squamous Cell Carcinoma Active, Not Recruiting 2025-01-27
Phase 1/2
NCT04349436 Study to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ… Merkel Cell Carcinoma Active, Not Recruiting 2026-04-22

Disease areas by active trials

Get alerts when Replimune, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free